Wednesday, May 05, 2010 12:28:56 PM
AMAG Pharmaceuticals shares fall following lower-than-expected 1st-quarter results
On Wednesday April 28, 2010, 2:06 pm EDT
NEW YORK (AP) -- Shares of AMAG Pharmaceuticals Inc. fell Wednesday after the biotechnology company reported a wider first-quarter loss and weaker revenue than Wall Street expected.
The stock shed $3.42, or 9.3 percent, to $33.36 in afternoon trading. Shares earlier reached a 52-week low of $31.90. They have ranged from $33.11 to $58.23 over the past year.
On Tuesday, the company said it lost $23.1 million, or $1.15 per share, on revenue of $13.3 million during the quarter. Analysts polled by Thomson Reuters, on average, had forecast a loss of 85 cents per share on revenue of $16.8 million.
The bulk of the company's revenue comes from Feraheme, which treats iron deficiency anemia in chronic kidney disease patients.
Jefferies & Co. analyst Eun K. Yang reaffirmed a "Hold" rating on the stock with a $32 price target, citing the lower-than-expected Feraheme sales and wider-than-expected first-quarter loss.
"While its potential in non-dialysis remains, disappointing first-quarter sales suggests challenges it (Feraheme) faces in the competitive, pricing-sensitive intravenous iron market, with little advantages," Yang wrote in a note to investors.
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM